Cost-efficacy analysis of fluticasone propionate versus zafirlukast in patients with persistent asthma

PharmacoEconomics

Volumn 19, Issue 8, 2001, Pages 865-874

  Menendez, Rogelio ^a   Stanford, Richard H ^b   Edwards, Lisa ^b   Kalberg, Christopher ^b   Rickard, Kathleen ^b  

^a Allergy and Asthma Center of El Paso   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO; SALBUTAMOL; ZAFIRLUKAST;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG COST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; COST-BENEFIT ANALYSIS; FEMALE; HOSPITALIZATION; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS; TOSYL COMPOUNDS; TREATMENT OUTCOME;

EID: 0034878857     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200119080-00008     Document Type: Article

References (30)

1. CDC surveillance summaries; 1998 Apr 24
2. Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis
3. US asthma mortality, 1941-1989
4. International trends in asthma mortality, 1970-1985
5. The costs of asthma
6. An economic evaluation of asthma in the United States
7. A national estimate of the economic costs of asthma
8. Cost and effects of inhaled corticosteroids plus bronchodilator therapy versus monotherapy in children with asthma
9. Cost and effects of inhaled corticosteroids and bronchodilators in asthma and chronic obstructive pulmonary disease
10. The effect of inhaled fluticasone propionate 100 mg bid compared with oral ZA 20mg bid on bronchial hyperresponsiveness
11. Inhaled fluticasone propionate and oral ZA in moderate asthma: A clinical and cost comparison
12. A statistical comparison of the efficacy of leukotriene modifiers and inhaled corticosteroids
13. Low dose inhaled fluticasone propionate vs oral ZA in the treatment of persistent asthma
14. Charge what you will: Reimbursements are shrinking
15. The cost of asthma in the emergency department and hospital
16. Is high dose fluticasone propionate via metered dose inhaler and volumatic as efficacious as nebulised budesonide in adult asthmatics?
17. Fluticasone propionate: An audit of outcomes and cost-effectiveness in primary care
18. Ease of handling and clinical efficacy of fluticasone propionate Accuhaler/Disk us inhaler compared with the budesonide Turbohaler inhaler in paediatric patients
19. A comparison of the cost-effectiveness of alternative prophylactic therapies in the treatment of adult asthma
20. The cost-effectiveness of inhaled fluticasone propionate and budesonide in the treatment of asthma in adults and children
21. National Asthma Education and Prevention Program Task Force on the cost effectiveness, quality of care, and financing of asthma care
22. Inhaled steroids and the risk of hospitalization for asthma
23. Explaining drug spending trends: Does perception match reality?
24. Low-dose inhaled corticosteroids and the prevention of death from asthma